Suchergebnisse
Suchergebnisse:
3. Feb. 2016 · Abbott to Acquire Alere. Under the terms of the agreement, Abbott will pay $56 per common share at a total expected equity value of $5.8 billion. Once the transaction is completed, Abbott will become the leading diagnostics provider of point of care testing. Abbott's total diagnostics sales will exceed $7 billion after the close.
Alere Technologies AS supplier profile. Cedarlane provides high-quality research reagents for the life science community. We have access to over 1400 industry-leading global life science suppliers. Call us now at 1(800)-268-5058. 0 +1 800 268-5058. Regist ...
Registers for ALERE TECHNOLOGIES LIMITED (SC277069) More for ALERE TECHNOLOGIES LIMITED (SC277069) Registered office address Axis-shield Diagnostics Limited, The Technology Park Luna Place, Dundee Technology Park, Dundee, DD2 1XA . Company status Active ...
AS100 Analyzer Product Demo Library. The Alere Afinion™ AS100 Analyzer is a compact, rapid, multi-assay analyzer that provides valuable near patient testing at the point-of-care. The analyzer is designed to enable simple and fast on-the-spot testing, regardless of the sample type which may be whole blood, plasma or urine. Module 1: The Alere ...
Alere Technologies GmbH. Ilmstr. 8, 07743 Jena-Löbstedt. 03641 31 11-0. Webseite. Anfahrt mit Bus und Bahn.
Use this density gradient medium for rapid, simple, and reliable cell isolation from most blood samples obtained from normal individuals and patients. You can substitute Lymphoprep™ for Ficoll-Paque™ without changing your existing protocols and achieve similar cell purity and recovery rates. This medium is fully compatible with both SepMate ...
Alere Technologies AS (vorher Axis-Shield PoC AS) “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global ...
